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Abstract
Background: Association of mitochondrial haplogroup J with longevity has been reported in several population subgroups.
While studies from northern Italy and Finland, have described a higher frequency of haplogroup J among centenarians in
comparison to non-centenarian, several other studies could not replicate these results and suggested various explanations
for the discrepancy.
Methodology/Principal Findings: We have evaluated haplogroup frequencies among Ashkenazi Jewish centenarians using
two different sets of matched controls. No difference was observed in the haplogroup J frequencies between the
centenarians or either matched control group, despite adequate statistical power to detect such a difference. Furthermore,
the lack of association was robust to population substructure in the Ashkenazi Jewish population. Given this discrepancy
with the previous reported associations in the northern Italian and the Finnish populations, we conducted re-analysis of
these previously published data, which supported one of several possible explanations: i) inadequate matching of cases and
controls; ii) inadequate adjustment for multiple comparison testing; iii) cryptic population stratification.
Conclusions/Significance: There does not exist a universal association of mitochondrial haplogroup J with longevity across
all population groups. Reported associations in specialized populations may reflect genetic or other interactions specific to
those populations or else cryptic confounding influences, such as inadequate matching attributable to population
substructure, which are of general relevance to all studies of the possible association of mitochondrial DNA haplogroups
with common complex phenotypes.
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Introduction
Studies of human mtDNA sequence variation have revealed a
remarkable partitioning of mtDNA haplogroups with geographic
origin of populations. Among Europeans, 95% of the population
belongs to 1 of 10 major haplogroups: H, I, J, K, M, T, U, V, W,
and X[1]. While the phylogeographic correlation of the mtDNA
haplogroups and geographic origins is very well established, the
question of whether the distribution of human mtDNA haplogroups
is the result of adaptation to the environment or the result of
random genetic drift with some modification by purifying selection
isstillunderdebate[2].Whilemost ofthehomoplasmicsubstitutions
(variations in mtDNA sequence affecting all mtDNA molecules
within a given individual) at deeper branches of the mtDNA tree
(among them, the haplogroup defining substitutions), are either
synonymous mutations, or appear in non-coding regions of the
mtDNA[2]; and are most probably selectively neutral, others such
as the Asian F haplogroup defining mutation 12406 alter a
moderately conserved amino acid[3]. Most of the studies describing
an association between mtDNA sequence variants and a well-
defined phenotype have focused on pedigree analysis, and have
reported heteroplasmic mutations (mutations that are present on
some, but not all, copies of the mtDNA sequence within a given
individual)[4], or rare homoplasmic variants. Consideration of the
possible phenotypic effects of non-synonymous homoplasmic
substitutions that define deeper mtDNA phylogeographic branch-
points has suggested that such substitutions have either not yet been
eliminated by purifying selection, or are not deleterious[2], and
might even be beneficial. A number of association studies reported
positive associations between mtDNA homoplasmic substitutions
andvariousphenotypes[5–8].Onespecificassociationthathasbeen
reported is that of longevity with haplogroup J in both a northern
Italian population[9], a Finnish population[10] and a and a sub-
branch of haplogroup J was enriched among Irish centenarians[11].
However other studies in French[12], and southern Italian[13]
populations could not replicate these results.
Given the inconsistency among the different studies, we have
decided to examine the possible association haplogroup J with
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Jews (AJ). Several studies have documented the homogeneity of
the AJ poulation, attributed to a strong founder effect, followed by
a rapid population expansions and a mating pattern characterized
by high levels of endogamy[14] and consanguinity[15]. These
population attributes enhance the power of genetic association
studies for complex phenotypes. Indeed, specific mutations in a
number of disease genes (e.g., breast cancer gene, adenomatosis
polyposis coli gene, hereditary prostate cancer gene and other)
were identified in the AJ population at higher prevalence and
replicated in other populations[16,17]. The propensity of variable
genetic background to modify phenotypic expression based on a
given genetic variant at a given locus (epistasis) is closely related to
the genetic diversity of the study population[18]. Together with
locus heterogeneity, low penetrance, variable expressivity, pleiot-
ropy, and limited statistical power[19], such epistatic effects can
confound the ability to identify a true association. On the other
hand the presence of cryptic population stratification, inadequate
matching of cases and controls within the study population, and
inadequate adjustment for multiple comparison testing can yield a
spurious association[20]. By focusing on a well defined highly
inbred population such as AJ, taking into account population
substructure, and with adequate matching and statistical analysis
adjustments, the genetic determinants of a particular phenotype
may be more homogeneous and hence more clearly identified, and
conversely false positive associations due to population stratifica-
tion can be avoided. Therefore, the AJ population seems to
provide an excellent opportunity to address the question of a
possible association of mitochondrial haplogroups with longevity,
and more specifically to understand the possible association
between longevity and haplogroup J.
Results
Haplogroup J
There was no difference in haplogroup J frequency in the
‘‘Longenity Project’’ control group 10/93 (10.75%), in comparison
to the Israeli control group 47/583 (8.06%) p=0.42. Furthermore
haplogroup J frequencies showed no differences between the
centenarian, and ‘‘Longenity Project’’ control group, the Israeli
control group or the joint control groups (8.3% vs. 10.75%,
8.06%, 8.43%, p=0.678, 0.68, 0.79, respectively, Table 1).
Population substructure
Comparison of the two control groups, yielded no differences in
the overall haplogroup frequencies (Table 1) p=0.254. The
comparison of overall mtDNA haplogroup distribution among
centenarians compared to each of the control groups (Table 1) did
not show any differences.
The overall haplogroup frequencies of Polish AJ and Romanian
AJ were similar (p=0.353) (Table 2), while the overall haplogroup
frequencies of Polish AJ were different in comparison to Ru\Uk
AJ (p=0.003), which is statistically significant while considering
Bonferroni correction for multiple hypothesis testing (a
0
v0:015).
No differences were detected in overall haplogroup frequencies in
comparing Romanian AJ and Ru\Uk AJ (p=0.142). Comparison
of the overall mtDNA haplogroup frequency between the
‘‘Longenity Project’’ subject centenarians and Israeli AJ control
subgroups (Pol, Rom, Ru\Uk) yielded Pearson chi-square values
respectively of p=0.149; p=0.695; p=0.037, and Fisher exact
test values respectively of p=0.535; p=0.691; p=0.498.
Discussion
Heritability estimates of longevity derived from twin registries
and large population-based samples suggest a significant but
modest genetic contribution to human lifespan (heritability ,15 to
30%)[21]. Associations of mtDNA haplogroup J with longevity
have been previously reported for two European populations
[9,10] and one sub-branch of haplogroup J was enriched among
Irish centenarians[11]. In contrast studies in other populations
could not replicate the association[11–13]. We sought to obtain
further clarity and insight by examining this association in a
population whose genetic structure has been well-characterized
and yielded successful associations with genomic loci in a variety of
complex phenotypes – namely the AJ population. Furthermore,
Table 1. Haplogroup frequencies among AJ centenarians and controls.
Haplogroup Centenarians % Spouses AJ % Israeli AJ %
A 1 0.41 0 0.00 1 0.17
H 61 25 22 23.66 119 20.41
HV 19 7.79 8 8.60 34 5.83
R0 5 2.05 3 3.23 16 2.74
I 5 2.05 1 1.08 5 0.86
J 20 8.3 10 10.75 47 8.06
K 70 28.69 27 29.03 186 31.90
L 3 1.23 1 1.08 10 1.72
M 4 1.64 0 0.00 11 1.89
N 16 6.64 4 4.30 59 10.12
T 8 3.28 9 9.68 28 4.80
U 7 2.87 3 3.23 34 5.83
V 13 5.33 5 5.38 19 3.26
W 5 2.05 0 0.00 8 1.37
X 4 1.64 0 0.00 6 1.03
Total 241 100 93 100.00 583 100
doi:10.1371/journal.pone.0003425.t001
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and adequately powered sample set of centenarians and controls
from the ‘‘Longenity Project’’, and then supplemented this with a
further control sample set. Moreover, and of perhaps greatest
importance – the subject group has already been used to uncover
longevity loci in the genome [22–25], giving still further
confidence that a negative result for a variant or locus of interest
is a true negative. Indeed we were not able to detect an association
of longevity with the J haplogroup using this study design.
A number of explanations can be offered to understand the
discrepancy. The first and most straightforward is population
specificity of the effect. According to this scenario, the association
of haplogroup J with longevity might be specific to those
populations in which the association was identified, and dependent
on epistatic effects with variants elsewhere in the genome in these
populations, or with environmental factors applicable to those
populations and not to AJ or other populations in which the
association could not be replicated. Such an explanation has very
important implications, since it would of course motivate the
search for such population specific modifiers, and corresponding
epistatic or gene-by-environment interactions. However, before
launching on such an endeavor it is necessary to consider other
possible explanations for the discrepant findings in the different
studies.
We have already considered the possibility that the current
study was inadequately powered to detect a true association.
Power analysis indicated that the likelihood of missing such an
association with the current study design was only 20%, for an
increase in haplogroup J frequency corresponding to an odds ratio
(OR) of 2.
Another possibility is that previously reported associations did
not take into account various confounding factors. For example,
low counts of haplogroup J in the study of northern Italian
centenarians and controls due to small sample size[9], would tend
to inflate the Chi
2 value and could potentially lead to the inference
of a false-positive association[26]. The reported association odds
ratio (i.e. 15) in this study[9], in the face of estimated 15–30%
heritability for this phenotype, suggests that this might have been
the case. Thus, even for this very high OR of 15, the power
calculated by Fisher’s test for the given sample sizes is 74.4%. In
the current study we used a much lower OR for the power
analysis, and this resulted in the requirement for a much larger
sample number for adequate power. Therefore, it is possible that
the observed association in the northern Italian study could result
from cryptic population stratification, equivalent to inadequate
matching of centenarian and control subjects. It has been recently
shown that matching for shared geographic origin and ethnic
affiliation may not be sufficient[27–29], and this is especially
important for association with mtDNA, because of the accentuated
subregional partitioning of mtDNA haplogroups[30]. For exam-
ple, recruitment of study participants within a small region or
village with relatively low immigration, can easily introduce bias in
the mtDNA haplogroup distribution, due to local regional founder
effects, i.e., the probability that apparently unrelated members
share a common maternal ancestor. In most societies, maternal
family name is usually not transmitted to the descendents[30].
Inspecting the populations in the northern Italian study reveals
that one of the populations sampled was from an isolated
mountainous and large plains region (i.e. Veneto). A phylogenetic
study of two villages (Barco and Posina) from this small geographic
region revealed notable differences in haplogroup J frequencies
(16.7% vs.5.3% respectively)[31]. Furthermore, haplogroup J
frequencies in northern Italy shows a remarkable variability: from
3.8% in Gardena[32] 14.5% in Tuscany[1] and 28.5% in
Fassa[31]. This large variability in haplogroup J frequency among
northern Italians would be expected to accentuate the confound-
ing effects of population stratification on association studies. The
overall haplogroup frequency distribution in the northern Italian
study was significantly different between male centenarians and
male controls, mainly due to an unexpectedly low frequency of
haplogroup J and high frequency of haplogroup U among the
controls, and it would be of interest to determine if there was a
Table 2. Haplogroup frequencies among AJ from various origins.
Haplogroup Poles AJ % Romanian AJ % Ru\Uk AJ %
A 0 00 00 0
H 22 12.94 24 24.74 33 25.98
HV 13 7.65 6 6.19 11 8.66
R0 2 1.18 1 1.03 7 5.51
I 3 1.76 0 0.00 0 0.00
J 18 10.59 10 10.31 14 11.02
K 65 38.24 29 29.90 21 16.54
L 5 2.94 2 2.06 1 0.79
M 3 1.76 2 2.06 1 0.79
N 10 5.88 11 11.34 11 8.66
T 6 3.53 3 3.09 9 7.09
U 12 7.06 5 5.15 11 8.66
V 6 3.53 1 1.03 5 3.94
W 4 2.35 1 1.03 3 2.36
X 1 0.59 2 2.06 0 0
Total* 170 100 97 100 127 100
Ru=Russians Uk=Ukrainians.
*AJs from other maternal geographic origins have been omitted from this table.
doi:10.1371/journal.pone.0003425.t002
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centenarians and controls. Indeed the extreme difference in
haplogroup distribution is first and foremost more likely to be
explained by differences in regional origin than association with a
given phenotype.
A similar concern arises in examining the results of the Finnish
longevity study[10]. In comparing the haplogroup J frequency
from the joint control groups in that study (33/657), to the
haplogroup J frequency in a sample of unrelated Finns 7/49 from
a different study[1] a significant difference (p=0.016), is evident,
indicating that population substructure in the Finnish population
may have conferred the inference of a causative association of
haplogroup J with longevity. This conclusion is further strength-
ened by comparing the haplogroup distributions within the
Finnish population as reported by Torroni et.al[1] to that of the
control groups from Neimi et.al[10]. This comparison reveals a
statistically significant (p=0.01) overall haplogroup difference only
in comparison with the infant group. In addition, it should be
noted that the study of Neimi et al.[10] tested 11 hypotheses,
necessitating, correction for multiple hypothesis testing for
rejection of the null hypothesis, which in the case of this study
would have required p,0.0046[33].
Notwithstanding these concerns – the fact that both the Finnish
as well as the northern Italian study found an association of
longevity with the same mtDNA haplogroup J certainly motivates
further investigation. In this regard, the design of our current study
in AJ was powered to identify an OR of 1.75 or higher. Therefore
it is certainly possible that a lower genetic contribution of
haplogroup J to longevity could not be detected by our current
study, and since the exact genetic contribution of mitochondrial
variants to the longevity phenotype is unknown and cannot be
reliably estimated from previous studies, we certainly cannot
exclude this possibility.
While the use of the ‘‘Longenity Project’’ spouse control group
dramatically enhances the reliability of matching of cases and
controls in terms of population stratification, the same approach
potentially introduces a different potential source of bias. As noted
above, the AJ population is both consanguineous and endoga-
mous[15]. In an inbred population such as AJ, centenarians and
their offspring spouses might share the same mtDNA haplogroup
due to consanguinity, a fact that might mask the association
between haplogroups and a given trait of interest. The use of the
Israeli control group in addition to the spouse based: ’’Longenity
Project’’ control group, importantly ameliorates this possible
source of bias. The overall absence of differences in mtDNA
haplogroup distributions between the ‘‘Longenity Project’’ and
Israeli control groups indicates that the matching was successful,
regardless of geography and consanguinity.
In a recent study, Feder et.al[29] described geographic
substructure among AJ living in Israel. Most of the substructure
effect in this study[29] stemmed from differential representation of
haplogroups K and H, among AJ originating from Poland,
Romania, and former Soviet Union, these results were demon-
strated in our AJ samples sets as well (Table 2). Importantly, no
difference was reported for haplogroup J frequencies among these
three groups in Feder et al.[29], nor in our sample sets. The fact
that AJ population substructure did not influence haplogroup J
frequency cannot be generalized to other haplogroups or to other
genetic loci, and future studies on genetic associations among AJ
should take into account the potential influence of cryptic
substructure based on European regional origin
While the current study tends to rule out a cross-population or
global association of the mtDNA J haplogroup with longevity, it
does not rule out other forms of association of mtDNA sequence
variation with lifespan. Several studies have tried to relate lower
frequency mtDNA polymorphisms to the longevity pheno-
type[11,12,34,35], or the appearance of somatic mutations in
the mitochondria of centenarians[36]. Furthermore, as already
noted – we cannot rule out the possibility of population-specific
effects of certain mtDNA haplogroups interacting with a given
nuclear genomic background or environment. This would require
further well-designed studies in other populations, taking into
account all of the potentially confounding factors outlined above.
Materials and Methods
Study population
This case-control study included 241 centenarians recruited as
part of the Albert Einstein College of Medicine ‘‘Longenity
Project’’: http://www.aecom.yu.edu/longenity/page.aspx?ID=
2982&ekmensel=1490_submenu_1492_btnlink, of whom 213
have been previously described[22,23] with an additional 28 for
the current study, and together are termed the ‘‘Longenity Project
subject group’’.
The centenarian ages were defined by birth certificates or dates
of birth as documented on passports. The mean age at recruitment
was 97.862.8, 168 were females and 73 males. Inclusion into the
centenarian group required that the subjects be living indepen-
dently when they were 95 years of age as a reflection of good
health, although at the time of recruitment they could be at any
level of dependency. The control population consisted of two
unrelated sample sets of AJ. The ‘‘Longenity Project control
group’’ included 93 individuals (36 males, and 57 females, who
were spouses of the offspring of the ‘‘Longenity Project subject
group’’, with 75 of them as described elsewhere [23], and 18
additional recruited for the current study. The mean age at
recruitment of this subgroup was 69.468.8 years. The second
control group consisted of Israeli AJ recruited in Israel as
previously described[37], and consists of a total of 583 AJ (417
males, and 166 females) with a mean age at recruitment of
41.8616.2 year (‘‘Israeli control group’’). It should be noted that
less than 0.01% of the control group are expected to become
centenarians[38], according to previous studies from other
populations, and therefore can be considered a suitable control
group. All the participants in the current study were interviewed,
their maternal origin was reported and they were all self identified
as being AJ.
Genotyping
Sequences of part of the control region were determined from
position 16024–300, by the use of the ABI Prism Dye Terminator
cycle-sequencing protocols developed by Applied Biosystems
(Perkin-Elmer). Haplogroups were defined on the basis of coding
region RFLPs and control region polymorphisms. RFLP typing of
coding-region sites that are diagnostic for the major mtDNA
haplogroups was performed hierarchically beginning with deep-
rooting markers of the mtDNA phylogeny[39]. The genotyping of
both Israeli and the USA groups has been performed in the
Technion laboratory as previously described[37].
Statistical analysis
Power analysis was conducted using two different methodolo-
gies. First, the standard Fisher’s test power calculation was
conducted using the following parameters: p=0.05 and an
increase in haplogroup J frequency corresponding to an odds
ratio (OR) of 2, with the control haplogroup frequency set to
8%[37]. Using these parameters, a sample size of 240 centenarians
and 670 controls was needed to yield 80% power. The second
Haplogroup J and Longevity
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generates power curves for European mtDNA haplogroup studies,
which derived a universal equation enabling power calculations for
prospective studies. We used this equation in order to calculate
power and sample size[40]. The following parameters were used:
Nscaled=8.5 (corresponding to 90%) NH=1 (for haplogroup J
only), p0=0.08, and increasing values of p1 from 0.09 to 0.16 were
used. For p1=0.13 (corresponding to OR of 1.75) Ncmin was 251.
For OR greater than 1.75 much higher number of cases and
controls were needed.
Equation 1 [40]
NCmin~NscaledNH
0:37 p1 1{p1 ðÞ zp0 1{p0 ðÞ ðÞ = p1{p0 ðÞ ðÞ
2
Nscaled is 8.5 for a p=0.05, 11 for a p=0.01, and 14 for a
p=0.001. NH=the number of haplogroups. p0 is the frequency of
the haplogroup in the control population, and p1 is the frequency
of the haplogroup in the cases. According to these calculations the
number of cases needed is equal to the number of controls[40].
Fisher exact tests were used to verify whether the frequency of
haplogroup J was different between centenarians and controls. We
used Pearson’s chi-square in order to evaluate overall haplogroup
frequency differences among the different study populations.
Population substructure
We utilized two approaches to preempt, assess and take into
account possible population stratification among AJ.,. First, as was
suggested by Raule et. al.[30] population stratification in mtDNA
association studies can be avoided by not concentrating the
recruitment within small or isolated areas and by checking that the
haplogroup distribution of the control samples matches the
expected distribution for that country or region, when available
and reliable[30]. Secondly we divided each of our sample sets to
the three major maternal geographic origins of AJ as has been
previously reported[29] also – Doron’s paper). We compared
mtDNA haplogroup distribution among these three geographic
regions: Poland (Pol), Romania (Rom), and former Soviet Union
(Russia (RU) and Ukraine (UK).
Informed consent
All samples reported were derived from buccal swab or blood
cell samples that were collected with written informed consent
according to protocols approved by the National Human Subjects
Review Committee in Israel, and Institutional Review board of
the Albert Einstein College of Medicine. All informed consent
were written.
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